Skip to main content
SpringerLink
Log in

Spezifische Immuntherapie bei IgE-vermittelten allergischen Erkrankungen im Kindes- und Jugendalter – eine Übersicht über in Österreich zugelassene/registrierte Allergenpräparate

Konsensus Report 2009 der AG Pneumologie und Allergologie der Österreichischen Gesellschaft für Kinder und Jugendheilkunde

Allergen-specific Immunotherapy for children and adolescents – a review on available products in Austria

  • Konsensus bericht
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

A pediatric consensus report on allergen-specific immunotherapy for children and adolescents is presented for Austria. Products on the market in Austria are presented and categorised according to studies performed on the target population of children and adolescents, their effectiveness and indication. In general, more clinical studies on children and adolescents are mandatory for most of the available allergen-specific immunotherapeutics. In addition, the use of allergen-specific immunotherapy in general should be promoted as the exclusive treatment with long-lasting effects in type I allergies in particular in children.

Zusammenfassung

Der Consensus Report zur Spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen im Kindes- und Jugendalter ist einerseits aufgrund des zunehmend größeren Angebotes an Allergenpräparaten entstanden. Andererseits besteht die ethische Verpflichtung Kinder und Jugendliche mit Allergenpräparaten zu behandeln, die auch in Studien an Kindern und Jugendlichen getestet worden sind (EU Regulative). Neben einer Auflistung aller in Österreich für den Gebrauch an Kindern zugelassener Allergenpräparate folgt eine differenzierte und kritische Betrachtung der Studienlandschaft. Neue Studien an Kindern sind zu fordern, gleichzeitig ist auch ein deutlicher Nachholbedarf in der Anwendung dieser sehr effektiven Behandlungsform IgE-vermittelter Allergien festzuhalten.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Referenzen

  • Coifman RE, Cox LS (2006) American Academy of Allergy, Asthma & Immunology member immunotherapy practice patterns and concerns. J Allergy Clin Immunol 2007 119: 1012–1013

    Article  Google Scholar 

  • Madsen F (2007) EAACI 'Standards for practical allergen-specific immunotherapy'. Allergy 62: 332

    Article  CAS  PubMed  Google Scholar 

  • Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ, et al (2007) Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 62: 317–324

    Article  CAS  PubMed  Google Scholar 

  • Malling HJ (1999) WHO position paper (summary) – allergen-immunotherapy: therapeutic vaccines for allergic diseases. Wien Med Wochenschr 149: 410–414

    CAS  PubMed  Google Scholar 

  • Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, et al (1998) Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 81: 401–405

    CAS  PubMed  Google Scholar 

  • Wilson DR, Lima MT, Durham SR (2005) Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60: 4–12

    Article  CAS  PubMed  Google Scholar 

  • Passalacqua G, Durham SR (2007) Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 119: 881–891

    Article  PubMed  Google Scholar 

  • Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S (2007) Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev CD001936

  • Abramson MJ, Puy RM, Weiner JM (2003) Allergen immunotherapy for asthma. Cochrane Database Syst Rev CD001186

  • Kleine-Tebbe J, Bergmann KC, Friedrichs F, Fuchs T, Jung K, Klimek L, et al (2006) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J 15: 56–74

    Google Scholar 

  • Regulation of (EC) No 1901/2006 the Euopean Parliament and of the Council of December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol1/reg_2006_1901/reg_2006_1901_en.pdf

  • Compalati E, Penagos M, Tarantini F, Passalacqua G, Canonica GW (2009) Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol 102: 22–28

    PubMed  Google Scholar 

  • Akdis M, Akdis CA (2007 Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119: 780–791

    Article  CAS  PubMed  Google Scholar 

  • Larche M, Akdis CA, Valenta R(2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6: 761–771

    Article  CAS  PubMed  Google Scholar 

  • Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J(1997) Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 27: 1131–1139

    Article  CAS  PubMed  Google Scholar 

  • Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR (1995) Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 154: 4187–4194

    CAS  PubMed  Google Scholar 

  • Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT(1993) Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 178: 2123–2130

    Article  CAS  PubMed  Google Scholar 

  • Faith A, Richards DF, Verhoef A, Lamb JR, Lee TH, Hawrylowicz CM (2003) Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: relevance to immunotherapy. Clin Exp Allergy 33: 1209–1215

    Article  CAS  PubMed  Google Scholar 

  • Till S, Walker S, Dickason R, Huston D, O'Brien F, Lamb J, et al (1997) IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis. Clin Exp Immunol 110: 114–121

    Article  CAS  PubMed  Google Scholar 

  • Wachholz PA, Nouri-Aria KT, Wilson DR, Walker SM, Verhoef A, Till SJ, et al (2002) Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1: Th2 cytokine ratios. Immunology 105: 56–62

    Article  CAS  PubMed  Google Scholar 

  • Francis JN, Till SJ, Durham SR (2003) Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111: 1255–1261

    Article  CAS  PubMed  Google Scholar 

  • Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102: 98–106

    Article  CAS  PubMed  Google Scholar 

  • Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al (2003) IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33: 1205–1214

    Article  CAS  PubMed  Google Scholar 

  • Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, et al (2004) Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 172: 3252–3259

    CAS  PubMed  Google Scholar 

  • Savolainen J, Jacobsen L, Valovirta E (2006) Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 61: 1184–1190

    Article  CAS  PubMed  Google Scholar 

  • Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, et al (2004) Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363: 608–615

    Article  CAS  PubMed  Google Scholar 

  • Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al (2004) Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199: 1567–1575

    Article  CAS  PubMed  Google Scholar 

  • Kinaciyan T, Jahn-Schmid B, Radakovics A, Zwolfer B, Schreiber C, Francis JN, et al (2007) Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 119: 937–943

    Article  CAS  PubMed  Google Scholar 

  • Bohle B (2007) The impact of pollen-related food allergens on pollen allergy. Allergy 62: 3–10

    Article  CAS  PubMed  Google Scholar 

  • Evans R, Pence H, Kaplan H, Rocklin RE (1976) The effect of immunotherapy on humoral and cellular responses in ragweed hayfever. J Clin Invest 57: 1378–1385

    Article  CAS  PubMed  Google Scholar 

  • Marcotte GV, Braun CM, Norman PS, Nicodemus CF, Kagey-Sobotka A, Lichtenstein LM, et al (1998) Effects of peptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol 101: 506–513

    Article  CAS  PubMed  Google Scholar 

  • Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, et al (1998) Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 101: 747–754

    Article  CAS  PubMed  Google Scholar 

  • Wachholz PA, Soni NK, Till SJ, Durham SR (2003) Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 112: 915–922

    Article  CAS  PubMed  Google Scholar 

  • Gleich GJ, Zimmermann EM, Henderson LL, Yunginger JW (1982) Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol 70: 261–271

    Article  CAS  PubMed  Google Scholar 

  • van Neerven RJ, Arvidsson M, Ipsen H, Sparholt SH, Rak S, Wurtzen PA (2004) A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation. Clin Exp Allergy 34: 420–428

    Article  CAS  PubMed  Google Scholar 

  • Löwer J, Becker W-M, Vieths S (2003) Regulatory control and standardization of allergenic extracts. Frankfurt/ Main: Druck- und Verlagshaus Sperlich. Arb Paul Ehrlich Inst. Bundesamt Sera Impfstoffe, 65–115

  • Kleine-Tebbe J, Fuchs T, Klimek L, Kuhr J, Lepp U, Niggemann B, et al (2001) Allergen immunotherapy – a position paper of the German society for allergology and clinical immunology. Pneumologie 55: 438–444

    Article  CAS  PubMed  Google Scholar 

  • Ariano R, Kroon AM, Augeri G, Canonica GW, Passalacqua G (1999) Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial. Allergy 54: 313–319

    Article  CAS  PubMed  Google Scholar 

  • Brewczynski PZ, Kroon AM (1999) Wirksamkeit und Verträglichkeit einer Immuntherapie mit modifizierten Gräserpollenallergenen. Allergologie 22: 411–420

    Google Scholar 

  • Drachenberg KJ, Heinzkill M, Urban E, Woroniecki SR (2003) Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MLP) for children and adolecents. Allergol et Immunopathol 31: 270–277

    Article  CAS  Google Scholar 

  • Drachenberg KJ, Pfeiffer P, Urban E (2001) Sublinguale Immuntherapie. Ergebnisse einer randomisierten, doppelblinden, plazebokontrollierten Multicenterstudie mit einem standardisierten Birken- und Gräser-/Roggenpollenextrakt. Allergologie 24: 525–534

    Google Scholar 

  • Zielen S, Metz D, Sommer E, Scherf H-P (2007) Kurzzeit-Immuntherapie mit Allergoiden und dem Adjuvans Monophosphoryl-Lipid-A. Allergologie 30: S1–S8

    Google Scholar 

  • Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Sackesen C, Kalayci O (2006) The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Pediatr Allergy Immunol 17: 396–407

    Article  PubMed  Google Scholar 

  • Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP (2006) Twelve-year follow-up after discontinuation of pre-seasonal grass pollen immunotherapy in childhood. Allergy 61: 198–201

    Article  CAS  PubMed  Google Scholar 

  • Eng PA, Reinhold M, Gnehm HP (2002) Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 57: 306–312

    Article  CAS  PubMed  Google Scholar 

  • Businco L, Zannino L, Cantani A, Corrias A, Fiocchi A, La Rosa M (1995) Systemic reactions to specific immunotherapy in children with respiratory allergy: a prospective study. Pediatr Allergy Immunol 6: 44–47

    Article  CAS  PubMed  Google Scholar 

  • Bousquet J, Lockey R, Malling HJ (2001) Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558–562

    Article  Google Scholar 

  • Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108: S147–334

  • Eng P, Gnehm HE, Joller-Jemelka HI (1994) Clinical and immunologenic effects of preseasonal hyposenitization in children with pollinosis. Monatsschr Kinderheilkd 142: 616–622

    Google Scholar 

  • Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, et al (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109: 251–256

    Article  PubMed  Google Scholar 

  • Fontana V, Holt LJ, Mainland D (1966) Effectiveness of hyposensitization therapy in ragweed hay-fever in children. JAMA 195: 985–992

    Article  CAS  PubMed  Google Scholar 

  • Weisnagel J (1979) Nouvel agent hyposensibilisant dans le traitement de la rhinite allergique saisonniere (fievre des foins) a l'herbe a poux chez lnfant: le MRTA (modified rag weed tyrosine adsorbate). Union Med Can 108: 685–690

    CAS  PubMed  Google Scholar 

  • Dreborg S, Agrell B, Foucard T, Kjellman NI, Koivikko A, Nilsson S (1986) A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 41: 131–140

    Article  CAS  PubMed  Google Scholar 

  • Roder E, Berger MY, de Groot H, van Wijk RG (2008) Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol 19: 197–207

    Article  PubMed  Google Scholar 

  • Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, et al (2007) Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62: 943–948

    Article  CAS  PubMed  Google Scholar 

  • Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, et al (2004) Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 114: 851–857

    Article  CAS  PubMed  Google Scholar 

  • Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N, et al (2004) Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 59: 491–497

    Article  CAS  PubMed  Google Scholar 

  • Mortemousque B, Bertel F, De Casamayor J, Verin P, Colin J (2003) House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 33: 464–469

    Article  CAS  PubMed  Google Scholar 

  • Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L, et al (2003) Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 33: 206–210

    Article  CAS  PubMed  Google Scholar 

  • Rolinck-Werninghaus C, Hamelmann E, Keil T, Kulig M, Koetz K, Gerstner B, et al (2004) The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy 59: 973–979

    Article  CAS  PubMed  Google Scholar 

  • Grosclaude M, Bouillot P, Alt R, Leynadier F, Scheinmann P, Rufin P, et al (2002) Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study. Int Arch Allergy Immunol 129: 248–253

    Article  CAS  PubMed  Google Scholar 

  • Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, et al (1999) Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 54: 819–828

    Article  CAS  PubMed  Google Scholar 

  • Clavel R, Bousquet J, Andre C (1998) Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 53: 493–498

    Article  CAS  PubMed  Google Scholar 

  • Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H (1994) A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 49: 309–313

    Article  CAS  PubMed  Google Scholar 

  • Bahceciler NN, Isik U, Barlan IB, Basaran MM (2001) Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 32: 49–55

    Article  CAS  PubMed  Google Scholar 

  • La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW (1999) Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 104: 425–432

    Article  CAS  PubMed  Google Scholar 

  • Ullrich D, Thum-Oltimer S, Mussler S, Jaeschke B (2007) Successful specific subcutaneous immunotherapy (SCIT) with non-modified semi-depot pollen and mite preparations. Allergo J 2007: 193–198

    Google Scholar 

  • Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, Andre C, et al (1998) Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 53: 662–672

    Article  CAS  PubMed  Google Scholar 

  • Inal A, Altintas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y (2007) Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 17: 85–91

    CAS  PubMed  Google Scholar 

  • Dolz I, Martinez-Cocera C, Bartolome JM, Cimarra M (1996) A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 51: 489–500

    CAS  PubMed  Google Scholar 

  • Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S (2001) Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 31: 1392–1397

    Article  CAS  PubMed  Google Scholar 

  • Rienzo VD, Minelli M, Musarra A, Sambugaro R, Pecora S, Canonica WG, et al (2005) Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 35: 560–564

    Article  PubMed  Google Scholar 

  • Marcucci F, Sensi L, Frati F, Bernardini R, Novembre E, Barbato A, et al (2003) Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites. Allergy 58: 657–662

    Article  CAS  PubMed  Google Scholar 

  • Valovirta E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J (2006) Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 61: 1177–1183

    Article  CAS  PubMed  Google Scholar 

  • Bordignon V, Parmiani S (2003) Variation of the skin endpoint in patients treated with sublingual specific immunotherapy. J Investig Allergol Clin Immunol 13: 170–176

    CAS  PubMed  Google Scholar 

  • Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP (1995) Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 23: 224–230

    CAS  Google Scholar 

  • Passalacqua G, Musarra A, Pecora S, Amoroso S, Antonicelli L, Cadario G, et al (2007) Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 18: 58–62

    Article  PubMed  Google Scholar 

  • Pajno GB, Vita D, Parmiani S, Caminiti L, La Grutta S, Barberio G (2003) Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 33: 1641–1647

    Article  CAS  PubMed  Google Scholar 

  • Ippoliti F, De Santis W, Volterrani A, Lenti L, Canitano N, Lucarelli S, et al (2003) Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 14: 216–221

    Article  PubMed  Google Scholar 

  • Tari MG, Mancino M, Monti G (1990) Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 18: 277–284

    CAS  Google Scholar 

  • Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, et al (2009) Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 123: 167–173 e7

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez F, Boquete M, Ibanez MD, de la Torre-Martinez F, Tabar AI (2006) Once daily sublingual immunotherapy without updosing--A new treatment schedule. Int Arch Allergy Immunol 140: 321–326

    Article  CAS  PubMed  Google Scholar 

  • Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F (2005) Dose dependence of immunological response to sublingual immunotherapy. Allergy 60: 952–956

    Article  CAS  PubMed  Google Scholar 

  • Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O, et al (2009) Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 123: 160–166 e3

    Article  CAS  PubMed  Google Scholar 

  • Bergmann KC (2003) [Specific immunotherapy in allergic asthma]. Pneumologie 57: 84–90

    Article  PubMed  Google Scholar 

  • Gillissen A, Bergmann KC, Kleine-Tebbe J, Schultze-Werninghaus G, Virchow JC Jr, Wahn U, et al (2003) Specific immunotherapy in allergic asthma. Dtsch Med Wochenschr 128: 204–209

    Article  CAS  PubMed  Google Scholar 

  • Bousquet J (1999) Specific immunotherapy in asthma. Allergy 54 [Suppl 56]: 37–38

    Article  PubMed  Google Scholar 

  • Bousquet J, Michel FB, Malling HJ (1995) Is allergen immunotherapy effective in asthma? A meta-analysis of randomized clinical trials. Am J Respir Crit Care Med 152: 1737–1738

    CAS  PubMed  Google Scholar 

  • Calamita Z, Saconato H, Pela AB, Atallah AN (2006) Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 61: 1162–1172

    Article  CAS  PubMed  Google Scholar 

  • Giovane AL, Bardare M, Passalacqua G, Ruffoni S, Scordamaglia A, Ghezzi E, et al (1994) A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 24: 53–59

    Article  CAS  PubMed  Google Scholar 

  • Hedlin G, Heilborn H, Lilja G, Norrlind K, Pegelow KO, Schou C, et al (1995) Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 96: 879–885

    Article  CAS  PubMed  Google Scholar 

  • Hedlin G, Graff-Lonnevig V, Heilborn H, Lilja G, Norrlind K, Pegelow K, et al (1991) Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. J Allergy Clin Immunol 87: 955–964

    Article  CAS  PubMed  Google Scholar 

  • Bertelsen A, Andersen JB, Christensen J, Ingemann L, Kristensen T, Ostergaard PA (1989) Immunotherapy with dog and cat extracts in children. Allergy 44: 330–335

    Article  CAS  PubMed  Google Scholar 

  • Roberts G, Hurley C, Turcanu V, Lack G (2006) Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 117: 263–268

    Article  PubMed  Google Scholar 

  • Wang H, Lin X, Hao C, Zhang C, Sun B, Zheng J, et al (2006) A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy 61: 191–197

    Article  CAS  PubMed  Google Scholar 

  • Zimmermann T, Meyer-Ehmsen K (1988) Diagnostik und Therapie der Sensibilisierung gegen Dermatophagoides pteronyssinus und Dermatophagoides farinae bei Kindern. Allergologie 11: 503–508

    Google Scholar 

  • Valovirta E, Viander M, Koivikko A, Vanto T, Ingeman L (1986) Immunotherapy in allergy to dog. Immunologic and clinical findings of a double-blind study. Ann Allergy 57: 173–179

    CAS  PubMed  Google Scholar 

  • Sundin B, Lilja G, Graff-Lonnevig V, Hedlin G, Heilborn H, Norrlind K, et al (1986) Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 77: 478–487

    Article  CAS  PubMed  Google Scholar 

  • Cevit O, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB (2007) Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children. J Investig Allergol Clin Immunol 17: 286–291

    CAS  PubMed  Google Scholar 

  • Shim JY, Kim BS, Cho SH, Min KU, Hong SJ (2003) Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability. Clin Exp Allergy 33: 52–57

    Article  CAS  PubMed  Google Scholar 

  • Pajno GB, Morabito L, Barberio G, Parmiani S (2000) Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 55: 842–849

    Article  CAS  PubMed  Google Scholar 

  • Pajno GB, Passalacqua G, Vita D, Caminiti L, Parmiani S, Barberio G (2004) Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial. Allergy 59: 883–887

    Article  CAS  PubMed  Google Scholar 

  • Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J (1997) Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99: 450–453

    Article  CAS  PubMed  Google Scholar 

  • Reha CM, Ebru A (2007) Specific immunotherapy is effective in the prevention of new sensitivities. Allergol Immunopathol (Madr) 35: 44–51

    Article  CAS  Google Scholar 

  • Purello-D'Ambrosio F, Gangemi S, Merendino RA, Isola S, Puccinelli P, Parmiani S, et al (2001) Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 31: 1295–1302

    Article  PubMed  Google Scholar 

  • Madonini E, Agostinis F, Barra R, Berra A, Donadio D, Pappacoda A, et al (2003) Long-term and preventive effects of sublingual allergen-specific immunotherapy: a retrospective, multicentric study. Int J Immunopathol Pharmacol 16: 73–79

    CAS  PubMed  Google Scholar 

  • Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM (2004) Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 351: 668–674

    Article  CAS  PubMed  Google Scholar 

  • Schafer T, Ring J (1997) Epidemiology of allergic diseases. Allergy 52: 14–22; discussion 35–36

    Article  CAS  PubMed  Google Scholar 

  • Menardo JL, Bousquet J, Ville G, Michel FB (1983) Desensitisation with hymenoptera venom in children. Arch Fr Pediatr 40: 543–547

    CAS  PubMed  Google Scholar 

  • Urbanek R, Forster J, Kuhn W, Ziupa J (1985) Discontinuation of bee venom immunotherapy in children and adolescents. J Pediatr 107: 367–371

    Article  CAS  PubMed  Google Scholar 

  • Valentine MD, Schuberth KC, Kagey-Sobotka A, Graft DF, Kwiterovich KA, Szklo M, et al (1990) The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 323: 1601–1603

    Article  CAS  PubMed  Google Scholar 

  • Steiss JO, Jodicke B, Lindemann H (2006) A modified ultrarush insect venom immunotherapy protocol for children. Allergy Asthma Proc 27: 148–150

    PubMed  Google Scholar 

  • Laurent J, Smiejan JM, Bloch-Morot E, Herman D (1997) Safety of Hymenoptera venom rush immunotherapy. Allergy 52: 94–96

    Article  CAS  PubMed  Google Scholar 

  • Schuetze GE, Forster J, Hauk PJ, Friedl K, Kuehr J (2002) Bee-venom allergy in children: long-term predictive value of standardized challenge tests. Pediatr Allergy Immunol 13: 18–23

    Article  PubMed  Google Scholar 

  • Przybilla B, Rueff F (1999) [Desensitization of allergy to hymenoptera venoms]. Wien Med Wochenschr 149: 421–428

    CAS  PubMed  Google Scholar 

  • Wenzel J, Meissner-Kraemer M, Bauer R, Bieber T, Gerdsen R (2003) Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy 58: 1176–1179

    Article  CAS  PubMed  Google Scholar 

  • Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, et al (2007) Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 120: 164–170

    Article  CAS  PubMed  Google Scholar 

  • Werfel T, Breuer K, Rueff F, Przybilla B, Worm M, Grewe M, et al (2006) Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61: 202–205

    Article  CAS  PubMed  Google Scholar 

  • Leroy B, Lachapelle JM, Jacquemin MG, Saint-Remy JM (1993) Immunotherapy of atopic dermatitis by injections of antigen-antibody complexes. Dermatology 186: 276–277

    Article  CAS  PubMed  Google Scholar 

  • Ring J (1982) Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins. Br J Dermatol 107: 597–602

    Article  CAS  PubMed  Google Scholar 

  • Warner JO, Price JF, Soothill JF, Hey EN (1978) Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet 2: 912–915

    Article  CAS  PubMed  Google Scholar 

  • Glover MT, Atherton DJ (1992) A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 22: 440–446

    Article  CAS  PubMed  Google Scholar 

  • Cadario G, Galluccio AG, Pezza M, Appino A, Milani M, Pecora S, et al (2007) Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin 23: 2503–2506

    Article  CAS  PubMed  Google Scholar 

  • Mastrandrea F, Serio G, Minelli M, Minardi A, Scarcia G, Coradduzza G, et al (2000) Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol Immunopathol (Madr) 28: 54–62

    CAS  Google Scholar 

  • Werfel T, Aberer W, Augustin M, Biedermann T, Fölster-Holst R, Friedrichs F, et al (2008) Leitlinien: Neurodermitis. AWMW online 2008

  • Potter PC (2006) Update on sublingual immunotherapy. Ann Allergy Asthma Immunol 96: S22–S25

    Article  CAS  PubMed  Google Scholar 

  • Wilson DR, Torres LI, Durham SR (2003) Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003: CD002893

  • Pajno GB (2007) Sublingual immunotherapy: the optimism and the issues. J Allergy Clin Immunol 119: 796–801

    Article  PubMed  Google Scholar 

  • Passalacqua G, Guerra L, Pasquali M, Canonica GW (2006) Non-injection routes for allergen immunotherapy: focus on sublingual immunotherapy. Inflamm Allergy Drug Targets 5: 43–51

    Article  CAS  PubMed  Google Scholar 

  • Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, et al (2006) Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 97: 141–148

    Article  CAS  PubMed  Google Scholar 

  • Roder E, Berger MY, de Groot H, Gerth van Wijk R (2008) Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial. Clin Exp Allergy 38: 1659–1667

    Article  CAS  PubMed  Google Scholar 

  • Pajno GB, Vita D, Caminiti L, Arrigo T, Lombardo F, Incorvaia C, et al (2005) Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 116: 1380–1381

    Article  PubMed  Google Scholar 

  • Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U (2005) Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 60: 1459–1470

    Article  CAS  PubMed  Google Scholar 

  • Nielsen L, Johnsen CR, Mosbech H, Poulsen LK, Malling HJ (1996) Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 97: 1207–1213

    Article  CAS  PubMed  Google Scholar 

  • Jarisch R, Gotz M, Aberer W, Sidl R, Stabel A, Zajc J, et al (1988) Reduction of side effects of specific immunotherapy by premedication with antihistaminics and reduction of maximal dosage to 50.000 SQ-U/ml. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M, pp163–175

  • Brockow K, Kiehn M, Riethmuller C, Vieluf D, Berger J, Ring J (1997) Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100: 458–463

    Article  CAS  PubMed  Google Scholar 

  • Reimers A, Hari Y, Muller U (2000) Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 55: 484–488

    Article  CAS  PubMed  Google Scholar 

  • Muller UR, Jutel M, Reimers A, Zumkehr J, Huber C, Kriegel C, et al (2008) Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy. J Allergy Clin Immunol 122: 1001–1007 e4

    Article  PubMed  CAS  Google Scholar 

  • Malling HJ (2000) Minimising the risks of allergen-specific injection immunotherapy. Drug Saf 23: 323–332

    Article  CAS  PubMed  Google Scholar 

  • Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D (2001) Neubewertung des Risikos von Test- und Therapieallergenen. Eine Analyse der UAW-Meldungen von 1991 bis 2000. Bundesgesundheitsbl. Gesundheitsforsch. Gesundheitsschutz 44: 709–718

    Google Scholar 

  • Simons FE (2004) First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 113: 837–844

    CAS  PubMed  Google Scholar 

  • Simons FE, Gu X, Johnston LM, Simons KJ (2000) Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics 106: 1040–1044

    Article  CAS  PubMed  Google Scholar 

  • Sheikh A, Shehata YA, Brown SG, Simons FE (2009) Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy 64: 204–212

    Article  CAS  PubMed  Google Scholar 

  • Simons FE (2003) H1-Antihistamines: more relevant than ever in the treatment of allergic disorders. J Allergy Clin Immunol 112: S42–52

    Article  CAS  PubMed  Google Scholar 

  • Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al (2005) Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 115: 584–591

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Univ.-Klinik für Kinder und Jugendheilkunde, Austria

    Zsolt Szépfalusi & Dieter Koller

  2. Allergieambulatorium Rennweg, Wien, Austria

    Waltraud Emminger

  3. Abteilung für Kinder- und Jugendheilkunde im Klinikum Wels – Grieskirchen, Austria

    Franz Eitelberger

  4. Floridsdorfer Allergiezentrum, Wien, Austria

    Manfred Götz

  5. Abteilung für Kinder- und Jugendheilkunde, Landeskinderklinik Linz, Linz, Austria

    Andrea Grillenberger

  6. Univ.-Klinik für Kinder und Jugendheilkunde, Innsbruck, Austria

    Elisabeth Horak

  7. Univ.-Klinik für Kinder- und Jugendheilkunde, Paracelsus Medizinische Privatuniversität, Austria

    Isidor Huttegger

  8. LKH-Klagenfurt, Abteilung für Kinder- und Jugendheilkunde, Klagenfurt, Austria

    Helmut Litscher

  9. Facharzt für Kinder und Jugendheilkunde, Wien, Austria

    Rudolf Schmitzberger

  10. Univ.-Klinik für Kinder und Jugendheilkunde, Klinische Abteilung für Pulmonologie und Allergologie, Graz, Austria

    Eva-Maria Varga

  11. Abteilung für Kinder und Jugendheilkunde, Kardinal Schwarzenberg'sches Krankenhaus, Leiter der AG Pneumologie und Allergologie der Österreichischen Gesellschaft für Kinder und Jugendheilkunde, Austria

    Josef Riedler

Authors
  1. Zsolt Szépfalusi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Waltraud Emminger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Franz Eitelberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manfred Götz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrea Grillenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elisabeth Horak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Isidor Huttegger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dieter Koller
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Helmut Litscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rudolf Schmitzberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Eva-Maria Varga
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Josef Riedler
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

für die Österreichische Gesellschaft für Kinder,Jugendheilkunde

Corresponding author

Correspondence to Zsolt Szépfalusi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szépfalusi, Z., Emminger, W., Eitelberger, F. et al. Spezifische Immuntherapie bei IgE-vermittelten allergischen Erkrankungen im Kindes- und Jugendalter – eine Übersicht über in Österreich zugelassene/registrierte Allergenpräparate. Wien Klin Wochenschr 121, 648–660 (2009). https://doi.org/10.1007/s00508-009-1258-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-009-1258-8

Keywords

Schlüsselwörter

Search

Navigation